Page last updated: 2024-08-16

zardaverine and rolipram

zardaverine has been researched along with rolipram in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (50.00)18.2507
2000's6 (27.27)29.6817
2010's5 (22.73)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbosa, J; Barrish, JC; Brown, B; Dodd, JH; Donaldson, K; Guo, J; Huynh, T; Kiener, PA; Leftheris, K; Pitts, WJ; Poss, MA; Roberge, JY; Starling, GC; Vaccaro, W; Watson, A1
Artis, DR; Bollag, G; Card, GL; England, BP; Fong, D; Gillette, S; Ibrahim, PN; Kim, SH; Lee, B; Luu, C; Milburn, MV; Powell, B; Schlessinger, J; Suzuki, Y; Tabrizizad, M; Zhang, KY1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Jabaris, SS; Kodimuthali, A; Pal, M1
Barlow, DJ; Ehrman, TM; Hylands, PJ1
Chen, G; Ke, H; Kunz, S; Martinelli, S; Robinson, H; Seebeck, T; Wan, Y; Wang, H1
Barreiro, EJ; Bourguignon, JJ; Cardozo, SV; Fraga, CA; Justiniano, H; Kümmerle, AE; Lopes, AB; Lugnier, C; Martins, MA; Romeiro, NC; Schmitt, M; Villa, P1
de Esch, IJ; de Graaf, C; Jansen, C; Kanev, GK; Kooistra, AJ; Leurs, R1
Bielska, M; Bruno, O; Bull, JA; Fossa, P; Giordanetto, F; Guariento, S; Iwanowa, X; Karawajczyk, A; Marchini, G1
Gaal, L; Illes, P; Schudt, C1
Dent, G; Magnussen, H; Nakashima, M; Rabe, KF; Schudt, C; Tenor, H1
Hatzelmann, A; Schudt, C; Tenor, H1
Dent, G; Liebig, S; Magnussen, H; Rabe, KF; Schudt, C; Tenor, H1
Barnes, PJ; Dent, G; Evans, PM; Giembycz, MA; Rabe, KF1
Bochnowicz, S; Hay, DW; Kotzer, CJ; Luttmann, MA; Osborn, RR; Torphy, TJ; Underwood, DC1
Schade, FU; Schudt, C1
Fischer, W; Schudt, C; Wendel, A1
Banner, KH; Bertin, B; Moodley, I; Page, CP1
Cheng, JB; Cohen, VL; Jayasinghe-Beck, R; Turner, CR; Watson, JW; Wright, KF1
Enke, B; Ghofrani, HA; Grimminger, F; Schermuly, RT; Schudt, C; Seeger, W; Walmrath, D; Weissmann, N1
Cunningham, FM; Lees, P; Page, CP; Rickards, KJ1
Branscheid, D; Dent, G; Magnussen, H; Rabe, KF; Rühlmann, E; Schmidt, DT; Watson, N1

Reviews

1 review(s) available for zardaverine and rolipram

ArticleYear
Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.
    Journal of medicinal chemistry, 2008, Sep-25, Volume: 51, Issue:18

    Topics: Asthma; Humans; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive

2008

Other Studies

21 other study(ies) available for zardaverine and rolipram

ArticleYear
Identification of purine inhibitors of phosphodiesterase 7 (PDE7).
    Bioorganic & medicinal chemistry letters, 2004, Jun-07, Volume: 14, Issue:11

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Binding Sites; Cell Line; Cyclic Nucleotide Phosphodiesterases, Type 7; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Ligands; Purines; Structure-Activity Relationship; T-Lymphocytes

2004
Structural basis for the activity of drugs that inhibit phosphodiesterases.
    Structure (London, England : 1993), 2004, Volume: 12, Issue:12

    Topics: Binding Sites; Crystallography, X-Ray; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Protein Structure, Tertiary

2004
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
In silico search for multi-target anti-inflammatories in Chinese herbs and formulas.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Anti-Inflammatory Agents; Crystallography, X-Ray; Cyclooxygenase 1; Cyclooxygenase 2; Databases, Factual; Drug Design; Drugs, Chinese Herbal; Enzyme Inhibitors; JNK Mitogen-Activated Protein Kinases; Medicine, Chinese Traditional; Models, Chemical; Models, Molecular; Molecular Conformation; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase 4 Inhibitors; Structure-Activity Relationship

2010
Biological and structural characterization of Trypanosoma cruzi phosphodiesterase C and Implications for design of parasite selective inhibitors.
    The Journal of biological chemistry, 2012, Apr-06, Volume: 287, Issue:15

    Topics: Amino Acid Sequence; Bridged Bicyclo Compounds, Heterocyclic; Catalytic Domain; Conserved Sequence; Crystallography, X-Ray; Drug Design; Kinetics; Molecular Sequence Data; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Protein Binding; Protein Structure, Secondary; Protozoan Proteins; Recombinant Proteins; Saccharomyces cerevisiae; Sulfonamides; Surface Properties; Trypanosoma cruzi

2012
Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors.
    Journal of medicinal chemistry, 2012, Sep-13, Volume: 55, Issue:17

    Topics: Administration, Oral; Animals; Drug Design; Female; Humans; Hydrazones; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Models, Molecular; Molecular Conformation; Phosphodiesterase 4 Inhibitors; Pneumonia

2012
PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design.
    Journal of medicinal chemistry, 2016, Aug-11, Volume: 59, Issue:15

    Topics: Databases, Protein; Dose-Response Relationship, Drug; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship

2016
Design and synthesis of 4,5,6,7-tetrahydro-1H-1,2-diazepin-7-one derivatives as a new series of Phosphodiesterase 4 (PDE4) inhibitors.
    Bioorganic & medicinal chemistry letters, 2017, 01-01, Volume: 27, Issue:1

    Topics: Azepines; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Design; Humans; Leukocytes, Mononuclear; Lipopolysaccharides; Molecular Structure; Phosphodiesterase 4 Inhibitors; Structure-Activity Relationship; Tumor Necrosis Factor-alpha

2017
Effects of phosphodiesterase inhibition on the excitability of hippocampal pyramidal neurons in vitro.
    European journal of pharmacology, 1991, Sep-04, Volume: 202, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Animals; Electric Stimulation; Evoked Potentials; Hippocampus; In Vitro Techniques; Isoproterenol; Male; Neurons; Phosphodiesterase Inhibitors; Pyramidal Tracts; Pyridazines; Pyrrolidinones; Rats; Rats, Inbred Strains; Rolipram

1991
Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors.
    The American journal of physiology, 1994, Volume: 266, Issue:5 Pt 1

    Topics: 1-Methyl-3-isobutylxanthine; Adult; Aged; Antihypertensive Agents; Carbachol; Colforsin; Cytosol; Dinoprost; Dose-Response Relationship, Drug; Female; Humans; Isoenzymes; Kinetics; Lung Neoplasms; Male; Middle Aged; Muscle Contraction; Muscle Relaxation; Muscle Tonus; Muscle, Smooth, Vascular; Nitroprusside; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pulmonary Artery; Purinones; Pyridazines; Pyrrolidinones; Rolipram

1994
Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
    British journal of pharmacology, 1995, Volume: 114, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Benzamides; Blood Proteins; Cell Separation; Complement C5a; Cyclic Nucleotide Phosphodiesterases, Type 4; Electromagnetic Fields; Eosinophil Granule Proteins; Eosinophil-Derived Neurotoxin; Eosinophils; Humans; Inflammation Mediators; Luminescent Measurements; Naphthyridines; Neurotoxins; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridazines; Pyridines; Pyrrolidinones; Ribonuclease, Pancreatic; Ribonucleases; Rolipram; Theophylline

1995
Phosphodiesterase isozymes modulating inherent tone in human airways: identification and characterization.
    The American journal of physiology, 1993, Volume: 264, Issue:5 Pt 1

    Topics: 1-Methyl-3-isobutylxanthine; 2',3'-Cyclic-Nucleotide Phosphodiesterases; Adult; Aged; Bucladesine; Colforsin; Dibutyryl Cyclic GMP; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Humans; In Vitro Techniques; Isoenzymes; Lung; Lung Neoplasms; Male; Middle Aged; Muscle Relaxation; Muscle Tonus; Muscle, Smooth; Nitroprusside; Purinones; Pyrazines; Pyridazines; Pyrrolidinones; Rolipram; Vital Capacity

1993
Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 271, Issue:3

    Topics: Adolescent; Adult; Aged; Albuterol; Cyclic AMP; Drug Synergism; Eosinophils; Female; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridazines; Pyrrolidinones; Respiratory Burst; Rolipram

1994
Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:1

    Topics: Animals; Antigens; Bronchial Spasm; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Drug Synergism; Eosinophils; Guanidines; Guinea Pigs; Histamine Antagonists; In Vitro Techniques; Isoenzymes; Leukotriene D4; Male; Phosphodiesterase Inhibitors; Plethysmography, Whole Body; Pulmonary Eosinophilia; Pyridazines; Pyrrolidinones; Rolipram; Trachea

1994
The specific type III and IV phosphodiesterase inhibitor zardaverine suppresses formation of tumor necrosis factor by macrophages.
    European journal of pharmacology, 1993, Jan-05, Volume: 230, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cardiovascular Agents; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 4; Epoprostenol; Isoenzymes; Lipopolysaccharides; Macrophages; Male; Mice; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Platelet Aggregation Inhibitors; Pyridazines; Pyrrolidinones; Rolipram; SRS-A; Tumor Necrosis Factor-alpha

1993
Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice.
    Biochemical pharmacology, 1993, Jun-22, Volume: 45, Issue:12

    Topics: Animals; Cells, Cultured; Colforsin; Cyclic AMP; Dinoprostone; Galactosamine; Hepatitis; Lipopolysaccharides; Liver; Macrophages; Male; Mice; Phosphodiesterase Inhibitors; Pyridazines; Pyrrolidinones; Rolipram; Shock, Septic; Tumor Necrosis Factor-alpha

1993
Effect of isoenzyme selective phosphodiesterase inhibitors on the proliferation of murine thymus and spleen cells.
    Pulmonary pharmacology, 1996, Volume: 9, Issue:1

    Topics: Animals; Cell Division; Female; Guanidines; Lymphocyte Activation; Mice; Phosphodiesterase Inhibitors; Pyridazines; Pyrrolidinones; Rolipram; Spleen; Thymus Gland

1996
Differential in vivo and in vitro bronchorelaxant activities of CP-80,633, a selective phosphodiesterase 4 inhibitor.
    Canadian journal of physiology and pharmacology, 1997, Volume: 75, Issue:8

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Animals; Bronchodilator Agents; Catecholamines; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Guinea Pigs; Male; Muscle Relaxation; Muscle, Smooth; Phosphodiesterase Inhibitors; Propranolol; Pyridazines; Pyrimidinones; Pyrrolidinones; Rolipram; Trachea

1997
Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension.
    American journal of respiratory and critical care medicine, 1999, Volume: 160, Issue:5 Pt 1

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Aerosols; Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epoprostenol; Hypertension, Pulmonary; Naphthyridines; Phosphodiesterase Inhibitors; Pulmonary Circulation; Purinones; Pyridazines; Rabbits; Rolipram; Vasoconstrictor Agents; Vasodilation

1999
Phosphodiesterase activity in neutrophils from horses with chronic obstructive pulmonary disease.
    Veterinary immunology and immunopathology, 2000, Oct-31, Volume: 76, Issue:3-4

    Topics: Animals; Dose-Response Relationship, Immunologic; Guanidines; Horse Diseases; Horses; Isoenzymes; Neutrophils; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pulmonary Disease, Chronic Obstructive; Pyridazines; Pyridines; Rolipram

2000
The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airways.
    British journal of pharmacology, 2000, Volume: 131, Issue:8

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Antigens, Dermatophagoides; Benzamides; Bronchi; Bronchodilator Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Glycoproteins; Histamine; Humans; In Vitro Techniques; Leukotriene C4; Lung Neoplasms; Muscle Contraction; Phosphodiesterase Inhibitors; Pyridazines; Pyridines; Rolipram; Theophylline

2000